Koru Lifescience
Pharmaceutical research and development organisation founded in 2017 focused on formulation and platform-based drug development, drug repurposing, and personalised/stratified medicine. Offers contract development and collaborative R&D services spanning formulation, analytical development, stability testing, a range of dosage forms, advanced manufacturing techniques and computational screening to accelerate development of therapies.
Industries
Nr. of Employees
medium (51-250)
Koru Lifescience
36 Copsey Place, Avondale, Auckland, 1026, New Zealand
Products
Drug Repurposing Platform
A platform that applies existing optimized compounds to new disease indications to shorten drug development time and find new therapeutic uses.
Personalised and Stratified Medicine Platform
A platform that develops tailored pharmaceutical dosage forms using 3D printing technology to create personalized medicines for individual patient needs.
Drug Repurposing Platform
A platform that applies existing optimized compounds to new disease indications to shorten drug development time and find new therapeutic uses.
Personalised and Stratified Medicine Platform
A platform that develops tailored pharmaceutical dosage forms using 3D printing technology to create personalized medicines for individual patient needs.
Services
Contract research and development services covering formulation development, analytical development, stability studies, regulatory and clinical affairs support and IP advisory.
Contract research and development services covering formulation development, analytical development, stability studies, regulatory and clinical affairs support and IP advisory.
Expertise Areas
- Formulation development
- Analytical development and stability testing
- Drug repurposing and repositioning
- Personalised and stratified medicine
Key Technologies
- 3D printing (Fused deposition modelling, Direct powder extrusion, SLS)
- Hot-melt extrusion
- Twin-screw extrusion
- Spray drying